Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2838
-0.0132 (-4.44%)
At close: Aug 6, 2026, 4:00 PM EDT
0.2940
+0.0102 (3.59%)
Pre-market: Aug 7, 2026, 7:02 AM EDT
Vistagen Therapeutics Employees
Vistagen Therapeutics had 41 employees as of March 31, 2026. The number of employees decreased by 16 or -28.07% compared to the previous year.
Employees
41
Change
-16
Growth
-28.07%
Revenue / Employee
$30,951
Profits / Employee
-$1,699,634
Market Cap
11.65M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Lunai Bioworks | 29 |
| Curis | 24 |
| Lisata Therapeutics | 21 |
| BioCardia | 21 |
| IN8bio | 18 |
| Theriva Biologics | 16 |
| Quoin Pharmaceuticals | 6 |
VTGN News
- 21 hours ago - Vistagen announces topline results from fasedienol repeat dose study - TheFly
- 22 hours ago - Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder - GlobeNewsWire
- 3 days ago - SRX Global acquires stake in Vistagen - TheFly
- 6 days ago - Vistagen Appoints Douglas J. Williamson to its Board of Directors - GlobeNewsWire
- 6 days ago - Vistagen Therapeutics Proxy statement: Proxy filing - Filings
- 6 days ago - Vistagen Therapeutics Proxy statement: Proxy filing - Filings
- 5 weeks ago - Vistagen Therapeutics Transcript: Study update - Transcripts
- 5 weeks ago - Vistagen Therapeutics Press release: Study update - Filings